Cargando…

Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials

Objective: Concerns exist regarding the potential development of malignancy and tuberculosis in patients with spondyloarthritis (SpA) treated with biologics. We assessed the extent to which biologic therapy may increase the risk of malignancy and tuberculosis in patients with SpA by meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Man, Siliang, Hu, Lidong, Ji, Xiaojian, Wang, Yiwen, Ma, Yingpei, Wang, Lei, Zhu, Jian, Huang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585981/ https://www.ncbi.nlm.nih.gov/pubmed/34776944 http://dx.doi.org/10.3389/fphar.2021.705669

Ejemplares similares

Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials
por: Hu, Lidong, et al.
Publicado: (2022)

Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials
por: Ji, Xiaojian, et al.
Publicado: (2022)

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China
por: Ji, Xiaojian, et al.
Publicado: (2019)

Characteristics Associated with the Occurrence and Development of Acute Anterior Uveitis, Inflammatory Bowel Disease, and Psoriasis in Patients with Ankylosing Spondylitis: Data from the Chinese Ankylosing Spondylitis Prospective Imaging Cohort
por: Man, Siliang, et al.
Publicado: (2021)

Underweight and obesity are strong predictors of clinical outcomes in patients with ankylosing spondylitis: data from the Smart-phone SpondyloArthritis Management System
por: Hu, Lidong, et al.
Publicado: (2021)

Add-On Effects of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs in Ankylosing Spondylitis: Data from a Real-World Registered Study in China
por: Man, Siliang, et al.
Publicado: (2020)

Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis
por: Zhou, Erye, et al.
Publicado: (2023)

Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study
por: Ji, Xiaojian, et al.
Publicado: (2019)

Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials
por: Li, Hongchao, et al.
Publicado: (2022)

An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review
por: Zhou, Xueliang, et al.
Publicado: (2022)

Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies
por: Lu, Jingli, et al.
Publicado: (2019)

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials
por: Jian, Changchun, et al.
Publicado: (2023)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wang, Jinjin, et al.
Publicado: (2020)

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
por: Wang, Peng-Fei, et al.
Publicado: (2017)

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
por: Sichen, Li, et al.
Publicado: (2023)

Risk of malignancies in patients with spondyloarthritis treated with biologics compared with those treated with non-biologics: a systematic review and meta-analysis
por: Kwan, Yu Heng, et al.
Publicado: (2020)

Effective Doses of Nalbuphine Combined With Propofol for Painless Gastroscopy in Adults: A Randomized Controlled Trial
por: Li, Shuangfeng, et al.
Publicado: (2021)

Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
por: Jia, Mengmeng, et al.
Publicado: (2022)

Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study
por: Xiao, Min, et al.
Publicado: (2019)

Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
por: Di Lernia, Vito, et al.
Publicado: (2022)

Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
por: Sarathy, Jansy P., et al.
Publicado: (2018)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: A meta-analysis of randomized controlled trials
por: Shi, Rui, et al.
Publicado: (2022)

The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials
por: Lei, Hong, et al.
Publicado: (2016)

Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies
por: Han, Xiao, et al.
Publicado: (2023)

Chinese Herbal Medicine Combined With Antiepileptic Drugs for Intractable Epilepsy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Ying, et al.
Publicado: (2022)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhu, Guanghui, et al.
Publicado: (2021)

A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
por: Ji, Songjun, et al.
Publicado: (2023)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
por: Ayoun Alsoud, Rami, et al.
Publicado: (2023)

Artemisitene: a promising natural drug candidate with various biological activities needs to confirm the interactional targets
por: Lin, Xian, et al.
Publicado: (2023)

Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials
por: Man, Changfeng, et al.
Publicado: (2020)

Integrated Random Negative Sampling and Uncertainty Sampling in Active Learning Improve Clinical Drug Safety Drug–Drug Interaction Information Retrieval
por: Xie, Weixin, et al.
Publicado: (2021)

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wang, Peile, et al.
Publicado: (2020)

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Consensus on targeted drug therapy for spondyloarthritis
por: Tian, Xinping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j14eneenn043gls1ghfqvl29qn